Last reviewed · How we verify
Placebo only
Placebo produces no direct pharmacological effect; any observed clinical benefit results from the placebo effect—psychological and physiological responses to the expectation of treatment.
Placebo produces no direct pharmacological effect; any observed clinical benefit results from the placebo effect—psychological and physiological responses to the expectation of treatment. Used for Used as control arm in phase 3 clinical trials (specific indication unknown without trial protocol).
At a glance
| Generic name | Placebo only |
|---|---|
| Also known as | Sugar Pill, placebo |
| Sponsor | Wayne State University |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo is an inert substance used as a control in clinical trials to measure the true efficacy of an active drug by accounting for natural disease progression, regression to the mean, and patient expectation effects. The placebo effect itself can involve neurobiological mechanisms including endogenous opioid release, dopamine signaling, and autonomic nervous system modulation, but the placebo vehicle itself has no active ingredient.
Approved indications
- Used as control arm in phase 3 clinical trials (specific indication unknown without trial protocol)
Common side effects
Key clinical trials
- The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. (NA)
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (PHASE2)
- Trial of Suvorexant for Sleep in Children With Autism (PHASE2)
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers (PHASE1)
- Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair (NA)
- Effect of Kinesio Taping Application in Addition to Pilates Exercises on Core Muscle Thickness, Cognition and Mental Fatigue in Individuals With Non-specific Low Back Pain (NA)
- Adenosine 2A Receptor Antagonism and AIH in ALS (PHASE1, PHASE2)
- A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo only CI brief — competitive landscape report
- Placebo only updates RSS · CI watch RSS
- Wayne State University portfolio CI